CarthroniX
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
43364 10th St W Ste A, Lancaster, Califo...Phone Number
(949) 885-1907Website
www.carthronix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About CarthroniX
CarthroniX is harnessing the regenerative power of a pathway classically associated with inflammation and pathology: gp130 and the IL-6 family of cytokines. By selectively biasing signaling outcomes from gp130, CarthroniX's small molecules empower unique results in pathological situations. CX-011, CarthroniX's first gp130 modulator, will begin human testing in a Phase 1/2a trial in 2023. Evaluation of other gp130 modulators in veterinary medicine as well as other human indications is actively ongoing.Explore more
CarthroniX Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CarthroniX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if CarthroniX is spiking on competitors!
Earning: See what the market has to say on CarthroniX recently announced quarterly report
Check if CarthroniX has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at CarthroniX
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once CarthroniX has new funding data
CarthroniX, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if CarthroniX had a recent Job posting/layoffs
Product Launch: Get notified when CarthroniX launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to CarthroniX
Compare insights from companies similar to CarthroniX, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CarthroniX
<$5M
1-10
Private
<$5M
2015
AN
Amir NobakhtCommercialization Chief Operating Officer & Director
Company Profile Activity
Activity Insights
CarthroniX is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CarthroniX is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CarthroniX.
CarthroniX financials insights
Gather financial insights about CarthroniX, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$15K
2022
Debt
$2.3M
CarthroniX Tech Stack
A closer look at the technologies used by CarthroniX
See more technologies
CarthroniX News & Media
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding CarthroniX
Sign Up For FreeTo access detailed company insights
CarthroniX is harnessing the regenerative power of a pathway classically associated with inflammation and pathology: gp130 and the IL-6 family of cytokines. By selectively biasing signaling outcomes from gp130, CarthroniX's small molecules empower unique results in pathological situations. CX-011, CarthroniX's first gp130 modulator, will begin huma... Read More
